Cancer does not progress in isolation. On the contrary, it builds around itself a complex ecosystem in which tumor, stromal, and immune cells constantly interact. Within this context, exosomes have evolved from being considered simple cellular byproducts to becoming key mediators of intercellular communication.
These extracellular vesicles, ranging from 30 to 150 nm, act as biological messengers capable of reprogramming cells at a distance. In cancer, their role is especially relevant in shaping an immunosuppressive tumor microenvironment, which is essential for tumor progression.
Tumor-derived exosomes (TEX) carry a highly selective molecular cargo that reflects the pathological state of the originating cell. Their composition includes proteins, lipids, messenger RNA, and microRNAs, all capable of modulating signaling pathways in recipient cells.
Beyond their content, what is truly relevant is their function: exosomes enable tumors to extend their influence beyond the local environment, affecting both local and systemic immune cells.
One of the most relevant effects of tumor-derived exosomes is their ability to profoundly alter the immune response. This process is not driven by a single mechanism but rather by a network of interactions that progressively promote immune evasion.
Under normal conditions, CD8+ T lymphocytes represent one of the main antitumor defense mechanisms. However, tumor-derived exosomes can interfere with this response by inducing apoptosis, reducing proliferation, and decreasing key cytokines such as IFN-γ.
The exosomal expression of molecules such as PD-L1, FasL, and TGF-β directly contributes to this state of immune dysfunction.
In parallel, exosomes promote a shift in immune balance toward a tolerogenic state. This is characterized by an increase in regulatory T cells (Tregs) and higher secretion of immunosuppressive cytokines such as IL-10.
This shift is not incidental; it is part of a broader tumor strategy to establish a sustained environment in which immune responses are actively suppressed.
The impact of exosomes is not limited to T cells. They also significantly influence macrophage plasticity, promoting polarization toward an M2 phenotype associated with tissue repair, angiogenesis, and immune suppression.
Similarly, natural killer (NK) cell cytotoxicity is reduced, partly due to the downregulation of activating receptors such as NKG2D and the transfer of immunomodulatory microRNAs.
One of the most sophisticated aspects of exosome-mediated communication is the transfer of microRNAs. These small non-coding RNAs can alter gene expression in recipient cells, acting as epigenetic regulators of immune responses.
MicroRNAs such as miR-21, miR-146a, and miR-155 are widely described in the tumor context due to their role in modulating inflammatory pathways and altering immune cell activation.
This mechanism adds an additional layer of complexity to the tumor microenvironment, enabling fine-tuned and sustained immunosuppression.
In recent years, growing evidence has shown that exosomes also participate in the regulation of immune checkpoints.
The presence of PD-L1 on tumor-derived exosomes is particularly relevant, as it may contribute to systemic T-cell inhibition even at sites distant from the primary tumor. This phenomenon may help explain certain cases of resistance to PD-1/PD-L1–based immunotherapies.
The study of exosomes in oncology has both biological and clinical relevance.
On one hand, their presence in biological fluids makes them ideal candidates for liquid biopsy applications, providing information on tumor burden, disease progression, and treatment response.
On the other hand, their functional role opens new therapeutic avenues, including:
Exosomes have evolved from accessory components of tumor biology into central players in the construction of the immunosuppressive tumor microenvironment.
Their ability to modulate multiple immune cell populations, alter immune responses, and promote tumor progression places them at the center of modern immuno-oncology research.
Understanding their function not only expands our view of cancer biology but also opens new paths toward more precise and effective therapeutic strategies.